Skip to main content

Table 3 Presentation of children with invasive non-typhoidal Salmonella infections by serovar in the 38 children whose isolates were serotyped

From: Invasive Salmonella infections among children in Bintulu, Sarawak, Malaysian Borneo: a 6-year retrospective review

Characteristic

All serovars

Salmonella Enteritidis

Salmonella Java

Other NTS serovars

P

No. of patients

38

17

9

12

–

Presenting symptoms

 Time between onset and admission, days, median (IQR)

2 (2–5)

3 (2–6)

3 (2–8)

2 (1–4)

0.1

 Fever

34 (89)

16 (94)

7 (78)

11 (92)

0.4

 Poor appetite

26 (68)

12 (71)

5 (56)

9 (75)

0.7

 Lethargy or irritability

23 (61)

9 (53)

5 (56)

9 (75)

0.5

 Cough

20 (53)

13 (77)

3 (33)

4 (33)

0.03

 URTI symptoms

17 (45)

10 (59)

3 (33)

4 (33)

0.4

 Diarrhea

15 (40)

4 (24)

6 (67)

5 (42)

0.1

 Vomiting

5 (13)

1 (6)

2 (22)

2 (17)

0.5

Presenting signs

 Signs of respiratory distress

26 (68)

15 (88)

4 (44)

7 (58)

0.05

 Tachycardia for age

24 (63)

13 (77)

6 (67)

5 (42)

0.2

 Tachypnoea for age

20 (53)

13 (77)

5 (56)

2 (17)

0.007

 Signs of dehydration

15 (40)

4 (24)

5 (56)

6 (50)

0.2

 Abnormal lung findingsa

13 (34)

9 (53)

1 (11)

3 (25)

0.1

 Hepatomegaly

9 (24)

7 (41)

0 (0)

2 (17)

0.08

 Pallor

7 (18)

4 (24)

1 (11)

2 (17)

0.9

 Poor perfusion

6 (16)

3 (18)

2 (22)

1 (8)

0.7

 Splenomegaly

2 (5)

2 (12)

0 (0)

0 (0)

0.5

Investigationsb

 Hemoglobin, g/dL, median (IQR)

11.4 (10.1–12.2)

11.5 (10.4–12.2)

11.4 (10.2–14.0)

10.5 (9.4–12.7)

0.5

 WBC, X 109 cells/L, median (IQR)

13.3 (9.7–18.3)

13.3 (9.5–17.6)

17.2 (10.3–20.3)

13.2 (8.5–17.6)

0.5

 Neut, X 109 cells/L, median (IQR)

5.7 (4.2–13.5)

5.7 (3.6–9.1)

6.4 (4.8–15.2)

6.2 (4.2–14.3)

0.7

 Lymph, X 109 cells/L, median (IQR)

5.4 (3.8–7.5)

5.8 (4.7–9.3)

5.8 (3.8–10.7)

4.4 (2.7–6.9)

0.3

 Platelet, X 109/L, median (IQR)

343 (251–463)

362 (185–459)

462 (313–492)

347 (238–487)

0.4

 ESR, mm/hr., median (IQR)

32 (10–48)

32 (10–41)

50 (24–75)

23 (6–61)

0.6

 Sodium, mmol/L, median (IQR)

136 (133–138)

137 (135–139)

134 (129–137)

135 (133–137)

0.1

 Urea, mmol/L, median (IQR)

3.1 (2.3–4.3)

2.7 (2.3–3.6)

3.5 (2.8–7.3)

3.4 (2.3–5.1)

0.4

 Albumin, g/L, median (IQR)

38 (35–44)

36 (34–44)

45 (43–46)

41 (34–46)

0.3

 AST, U/L, median (IQR)

51 (40–108)

49 (40–244)

98 (88–108)

48 (34–58)

0.4

 ALT, U/L median (IQR)

22 (16–90)

22 (16–82)

97 (85–109)

19 (15–94)

0.4

  1. Data are No. (%) unless otherwise indicated
  2. a All children with abnormal lung examination had bilateral findings: 6 had both rhonchi and crepitation, 6 only rhonchi and 1 only crepitation
  3. bOnly investigations done on the day of admission were included: 37 children had Hemoglobin, WBC, Platelet (Enteritidis, n = 17; Java, n = 8; Other serovars, n = 12); 27 children had differential counts (Enteritidis, n = 12; Java, n = 7; Other serovars, n = 8); 13 children had ESR (Enteritidis, n = 7; Java, n = 2; Other serovars, n = 4); 37 children had Sodium, Urea (Enteritidis, n = 17; Java, n = 9; Other serovars, n = 11); 15 children had Albumin, AST, ALT (Enteritidis, n = 9; Java, n = 2; Other serovars, n = 4)
  4. Abbreviations: IQR interquartile range, URTI upper respiratory tract infection, WBC white blood cell count, Neut neutrophil count, Lymph lymphocyte count, ESR erythrocyte sedimentary rate, AST aspartate aminotransferase, ALT alanine aminotransferase